Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jan 30, 2024 (3 years ago)

Equate Stye Lubricant Eye Ointment

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Equate Stye Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%), Packaged in 3.5 g tubes, Distributed by Walmart Inc., Bentonville, AR 72716, NDC 79903-028-35, UPC 681131395304

Affected NDC 79903-0028-35

Compare with the code on your package — it is the most precise check available.

Category: Eye Drops & Ophthalmic

Recalling firm
Brassica Pharma Pvt Ltd
NDC code
79903-028-35
Origin
India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0352-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Brassica Pharma Pvt Ltd

All 2024 recalls

Other sterility / contamination recalls from 2024

All sterility / contamination recalls
Class II · Moderate risk

ketamine inj 50 mg per 1 mL

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Terminated Sterility / contamination Hikma Injectables USA Inc NDC 63037-137-25 D-0173-2025